Peptide receptor radionuclide therapy with Y-DOTATOC and (177)Lu-DOTATOC in advanced neuroendocrine tumors: results from a Danish cohort treated in Switzerland
Andreas Klaus Pfeifer, Tine Gregersen, Henning Grønbæk, Carsten Palnæs Hansen, Jan Müller-Brand, Karin Herskind Bruun, Klaus Krogh, Andreas Kjær, Ulrich Knigge
84Citationer
(Scopus)
Fingeraftryk
Dyk ned i forskningsemnerne om 'Peptide receptor radionuclide therapy with Y-DOTATOC and (177)Lu-DOTATOC in advanced neuroendocrine tumors: results from a Danish cohort treated in Switzerland'. Sammen danner de et unikt fingeraftryk.